These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 9548196
1. The role of 99Tcm-tetrofosmin myocardial perfusion scintigraphy in the assessment of patients with previous myocardial infarction: a comparative study with 201Tl. Burak Z, Akin H, Buket S, Sagcan A, Argon M, Atay Y, Durmaz I, Duman Y. Nucl Med Commun; 1998 Feb; 19(2):127-36. PubMed ID: 9548196 [Abstract] [Full Text] [Related]
2. Comparison of dual-isotope acquisition of 201Tl and 99Tcm-tetrofosmin for the detection of ischaemic heart disease and determination of the optimal imaging time of 99Tcm-tetrofosmin. Ito Y, Uehara T, Fukuchi K, Tsujimura E, Hasegawa S, Nishimura T. Nucl Med Commun; 1998 Feb; 19(2):119-26. PubMed ID: 9548195 [Abstract] [Full Text] [Related]
3. Stress and rest myocardial SPET quantification with 201Tl and 99Tcm-tetrofosmin: a comparison. Moragas G, González JM, Buxeda M, Domènech FM, Ortega D, Castell J. Nucl Med Commun; 1998 Jul; 19(7):633-40. PubMed ID: 9853343 [Abstract] [Full Text] [Related]
4. Sublingual nitrate plus 99Tcm-tetrofosmin infusion in the detection of severely ischaemic but viable myocardium: a comparative study with stress, redistribution, reinjection and late redistribution 201Tl imaging. Derebek E, Kozan O, Durak H, Ergene O, Ozbilek E, Capa G, Belgi A, Yurekli Y, Degirmenci B, Dogan S. Nucl Med Commun; 1996 Oct; 17(10):864-71. PubMed ID: 8951907 [Abstract] [Full Text] [Related]
5. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. Matsunari I, Fujino S, Taki J, Senma J, Aoyama T, Wakasugi T, Hirai J, Saga T, Ichiyanagi K, Hisada K. J Nucl Med; 1995 Nov; 36(11):1961-7. PubMed ID: 7472582 [Abstract] [Full Text] [Related]
6. Simultaneous assessment of myocardial viability and function for the detection of hibernating myocardium using ECG-gated 99Tcm-tetrofosmin emission tomography: a comparison with 201Tl emission tomography combined with cine magnetic resonance imaging. Gunning MG, Anagnostopoulos C, Davies G, Knight CJ, Pennell DJ, Fox KM, Pepper J, Underwood SR. Nucl Med Commun; 1999 Mar; 20(3):209-14. PubMed ID: 10093069 [Abstract] [Full Text] [Related]
7. Technetium-99m-tetrofosmin regional myocardial uptake at rest: relation to severity of coronary artery stenosis in previous myocardial infarction. Cuocolo A, Soricelli A, Nicolai E, Squame F, Nappi A, Sullo P, Klain M, Cardei S, Salvatore M. J Nucl Med; 1995 Jun; 36(6):907-13. PubMed ID: 7769445 [Abstract] [Full Text] [Related]
12. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. Acampa W, Cuocolo A, Sullo P, Varrone A, Nicolai E, Pace L, Petretta M, Salvatore M. J Nucl Cardiol; 1998 Jun; 5(3):265-74. PubMed ID: 9669581 [Abstract] [Full Text] [Related]
13. [Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates]. Flotats Giralt A, Carrió Gasset I, Estorch Cabrera M, Bernà Roqueta L, Catafau Alcántara AM, Marí Aparici C, Ballester Rodés M. Rev Esp Cardiol; 1998 Jun; 51 Suppl 1():45-52. PubMed ID: 9549398 [Abstract] [Full Text] [Related]
14. Assessment of 99Tcm-tetrofosmin lung uptake: a modified method to avoid the contribution from high chest wall activity. Heiba SI, Ziada G, Higazy E, Saleh M, Elgazzar AH. Nucl Med Commun; 1998 Sep; 19(9):859-66. PubMed ID: 10581592 [Abstract] [Full Text] [Related]
15. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group. Zaret BL, Rigo P, Wackers FJ, Hendel RC, Braat SH, Iskandrian AS, Sridhara BS, Jain D, Itti R, Serafini AN. Circulation; 1995 Jan 15; 91(2):313-9. PubMed ID: 7805233 [Abstract] [Full Text] [Related]
16. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. Tamaki N, Takahashi N, Kawamoto M, Torizuka T, Tadamura E, Yonekura Y, Okuda K, Nohara R, Sasayama S, Konishi J. J Nucl Med; 1994 Apr 15; 35(4):594-600. PubMed ID: 8151381 [Abstract] [Full Text] [Related]
17. The routine use of sublingual GTN with resting 99Tcm-tetrofosmin myocardial perfusion imaging. Thorley PJ, Sheard KL, Wright DJ, Sivananthan UM. Nucl Med Commun; 1998 Oct 15; 19(10):937-42. PubMed ID: 10234673 [Abstract] [Full Text] [Related]
18. [Identification of viable myocardium using 99mTc-tetrofosmin scintigraphy--comparison with 201Tl redistribution-reinjection images]. Kobayashi H, Kawaguchi M, Oka T, Inoue S, Handa J, Asano R, Matsumoto N, Sumiyoshi T, Hosoda S, Kusakabe K. Kaku Igaku; 1995 Apr 15; 32(4):367-75. PubMed ID: 7776543 [Abstract] [Full Text] [Related]
19. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease. Matsunari I, Fujino S, Taki J, Senma J, Aoyama T, Wakasugi T, Hirai J, Saga T, Tonami N, Hisada K. Am J Cardiol; 1996 Feb 15; 77(5):350-4. PubMed ID: 8602561 [Abstract] [Full Text] [Related]
20. Technetium-99m-tetrofosmin imaging with incremental nitroglycerin infusion to detect severely ischaemic but viable myocardium: a comparative study with thallium-201. Kula M, Tutuş A, Unal S, Topsakal R, Ergin A. Nucl Med Commun; 2003 Sep 15; 24(9):987-94. PubMed ID: 12960598 [Abstract] [Full Text] [Related] Page: [Next] [New Search]